We are live on ! Find out more
Positive
Neutral
Negative
Sentiment 3-Months
Positive 41.2%
Neutral 47.1%
Negative 11.8%

Neutral
Zacks Investment Research
7 days ago
SUZ vs. KLBAY: Which Stock Is the Better Value Option?
Investors interested in Paper and Related Products stocks are likely familiar with Suzano S.A. Sponsored ADR (SUZ) and Klabin SA (KLBAY).
SUZ vs. KLBAY: Which Stock Is the Better Value Option?
Positive
Zacks Investment Research
7 days ago
Are Investors Undervaluing Suzano (SUZ) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Are Investors Undervaluing Suzano (SUZ) Right Now?
Negative
Zacks Investment Research
11 days ago
Buy 5 High ROE Stocks as Markets Get Embroiled in Middle-East Woes
ROST, SUZ, BBVA, GL and AME offer high ROE and cash-rich profiles as investors navigate renewed Middle East tensions.
Buy 5 High ROE Stocks as Markets Get Embroiled in Middle-East Woes
Neutral
Business Wire
19 days ago
Introducing Arbex: a New Global Leader in Tissue and Hygiene
LONDON--(BUSINESS WIRE)--Arbex, a new global leader in tissue and hygiene, today commences operations as an independent business and unveils details of its brand, leadership team, and company structure. Announced in June 2025 as a $3.4 billion joint venture between Suzano (NYSE: SUZ), the world's largest pulp supplier, and Kimberly-Clark Corporation (NASDAQ: KMB), a global leader in consumer goods and personal care, the new business will manufacture, market and distribute consumer and professio.
Introducing Arbex: a New Global Leader in Tissue and Hygiene
Positive
Zacks Investment Research
25 days ago
SUZ vs. KLBAY: Which Stock Should Value Investors Buy Now?
Investors looking for stocks in the Paper and Related Products sector might want to consider either Suzano S.A. Sponsored ADR (SUZ) or Klabin SA (KLBAY).
SUZ vs. KLBAY: Which Stock Should Value Investors Buy Now?
Positive
Zacks Investment Research
25 days ago
Should Value Investors Buy Suzano (SUZ) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Should Value Investors Buy Suzano (SUZ) Stock?
Negative
Zacks Investment Research
1 month ago
2 Paper and Related Products Stocks Set to Weather Industry Challenges
The near-term outlook for the Zacks Paper and Related Products industry is uncertain. Stocks like SUZ and MERC are braving the industry headwinds.
2 Paper and Related Products Stocks Set to Weather Industry Challenges
Neutral
Zacks Investment Research
1 month ago
SUZ or KLBAY: Which Is the Better Value Stock Right Now?
Investors with an interest in Paper and Related Products stocks have likely encountered both Suzano S.A. Sponsored ADR (SUZ) and Klabin SA (KLBAY).
SUZ or KLBAY: Which Is the Better Value Stock Right Now?
Positive
Zacks Investment Research
1 month ago
Are Investors Undervaluing Suzano (SUZ) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Are Investors Undervaluing Suzano (SUZ) Right Now?
Positive
Seeking Alpha
1 month ago
Suzano: Deleveraging Progress Is OK, Ignoring The Buyback And Some Non-Recurring Effects
Suzano S.A. is progressing with deleveraging, but at a slower pace than ideal due to excess CapEx and buybacks. Net debt reduction would have been approximately 5% in Q1 absent excess CapEx and buybacks, but actual reduction was closer to 2%. Suzano benefits from substantial input cost hedging and high fixed-rate debt exposure, mitigating capital cost risks and Brent price volatility, buying margins time despite Hormuz.
Suzano: Deleveraging Progress Is OK, Ignoring The Buyback And Some Non-Recurring Effects